Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Operating activities
Net income	$ 104,278	$ 9,752
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	200,105	191,785
Amortization of items charged to interest expense	5,523	4,730
Change in fair value of contingent purchase price	(1,111)	(5,944)
(Gain) loss on sale of property and equipment and assets held for sale	(3,440)	801
Income from unconsolidated affiliates	(11,662)	(11,895)
Distributions from unconsolidated affiliates	21,500	22,050
Deferred income taxes	2,059	50,460
Charge for stock-based compensation	4,554	6,446
Decrease (increase), net of businesses acquired
Accounts receivable	5,305	5,015
Prepaid expenses and other current assets	(4,231)	6,288
Other assets	(1,157)	8,869
(Decrease) increase, net of businesses acquired
Accounts payable	(8,492)	4,763
Accrued expenses	(2,489)	1,248
Accrued interest	1,611	3,680
Accrued salaries and wages	(18,262)	(862)
Gaming, pari-mutuel, property and other taxes	5,499	15,041
Income taxes	22,711	1,666
Other current and noncurrent liabilities	(10,780)	(7,748)
Net cash provided by operating activities	311,521	306,145
Investing activities
Capital project expenditures, net of reimbursements	(14,482)	(125,169)
Capital maintenance expenditures	(51,431)	(41,866)
Advances to the Jamul Tribe	(167,863)	(64,228)
Proceeds from sale of property and equipment and assets held for sale	13,212	389
Investment in joint ventures		(2,799)
Acquisition of businesses, gaming, and other licenses, net of cash acquired	(56,748)	(450,170)
Net cash used in investing activities	(277,312)	(683,843)
Financing activities
Proceeds from exercise of options	5,654	8,069
Principal payments on financing obligation with GLPI	(37,920)	(35,452)
Proceeds from issuance of long-term debt, net of issuance costs	74,170	517,290
Principal payments on long-term debt	(102,234)	(92,885)
Payments of other long-term obligations	(13,387)	(3,307)
Payments of contingent purchase price	(1,793)
Proceeds from insurance financing	9,614	885
Payments on insurance financing	(12,064)	(12,212)
Tax benefit from stock options exercised	8,510	10,126
Net cash (used in) provided by financing activities	(69,450)	392,514
Net (decrease) increase in cash and cash equivalents	(35,241)	14,816
Cash and cash equivalents at beginning of year	237,009	208,673
Cash and cash equivalents at end of period	201,768	223,489
Supplemental disclosure
Interest expense paid, net of amounts capitalized	339,211	321,276
Income tax (refunds received)/taxes paid	$ (11,720)	$ 879